Listen to the article
For years, a small scientific mystery has been housed in a quiet set of lab benches at Boston’s Beth Israel Deaconess Medical Center. Human fat tissue fragments—small, pale samples sealed in clear culture dishes—have been studied by researchers under bright fluorescent lights. The work appears routine at first glance. spreadsheets, pipettes, and microscopes. However, Harvard researchers think they have discovered something much more significant hidden within those cells: a genetic switch that might determine whether the body burns or stores fat.
The long-standing mystery surrounding a gene known as FTO, which geneticists have linked to obesity for over ten years, led to the discovery. Global genetic studies consistently revealed the connection. However, the mechanism continued to be oddly elusive. Many scientists believed for years that the gene affected appetite in the brain. That was a neat explanation. Perhaps too neat.
| Category | Details |
|---|---|
| Research Institutions | Harvard Medical School, MIT, Beth Israel Deaconess Medical Center |
| Lead Researcher | Melina Claussnitzer |
| Key Collaborator | Manolis Kellis (MIT CSAIL) |
| Journal | New England Journal of Medicine |
| Main Gene Identified | FTO gene region |
| Target Genes | IRX3 and IRX5 |
| Biological Mechanism | Switch between energy-storing white fat and energy-burning beige fat |
| Technology Used | CRISPR/Cas9 genome editing |
| Potential Impact | New therapies for obesity and metabolic diseases |
| Reference Source | https://hms.harvard.edu/news |
A different picture began to take shape when the Harvard-led team started examining epigenetic data from the Roadmap Epigenomics Project. Brain cells did not exhibit the strongest signals at all. Rather, they first appeared in preadipocytes, which are immature cells that develop into fat cells. The story is drastically changed by that seemingly insignificant detail. Long before food even enters the picture, the body’s fat system may be making decisions.
Obesity science seems to be gradually moving away from straightforward calorie math and toward something more biological, almost architectural, as this research develops. Two genes, IRX3 and IRX5, which are distant from the FTO region, were found to be important players in the Harvard study. Fat cells tend to store energy when these genes become very active. Cells start burning energy when they quiet down.
The difference seemed surprisingly stark in lab experiments. Researchers could force human precursor fat cells to adopt two distinct identities by modifying these genes. White fat, the well-known tissue that stores energy and builds up around the waist or hips, was the result of one route. Beige fat, a metabolically active form that burns calories to produce heat, was the result of the alternative route.
It sounds like a technical distinction. However, it is visible within the laboratory. Under a microscope, beige fat cells, which are densely packed with mitochondria and practically humming with metabolic activity, appear darker.
The most striking experiments were probably the ones involving mice. After suppressing the IRX3 gene in fat cells, researchers observed the results. The animals consumed food as usual. They made the same amount of movement. Their everyday behavior hasn’t changed in any noticeable way. However, their bodies became leaner and their metabolism subtly increased. The mice were roughly 50% thinner than their peers by the end of the experiment.
It’s easy to interpret that outcome as a nearly miraculous remedy for obesity. However, biology seldom produces miracles without complications. The researchers themselves seem wary. Whether safely altering this pathway in humans would yield comparable outcomes is still unknown. After all, fat tissue is intricately linked to numerous metabolic loops, hormones, and immune signals.
The genetic detail is still fascinating, though. A single nucleotide alteration in the FTO region—a tiny genetic letter swap from T to C—was identified by the Harvard team as the mechanism. This minor change releases control over IRX3 and IRX5 by weakening the binding of a regulatory protein known as ARID5B. When those genes become active during the early stages of fat cell development, the cells start storing energy instead of burning it. Put another way, a tiny genetic alteration could upset a body’s entire metabolic equilibrium.
The researchers employed CRISPR genome editing to test their hypothesis by alternating the nucleotide between its protective and risky forms in human cells. Similar to flipping a light switch, the cells’ metabolic behavior changed with each nucleotide change.
In scientific circles, the concept of a “metabolic switch” has begun to gain popularity. However, the phrase seems to be both true and a little deceptive. There is never a single lever that controls metabolism. Rather, it looks like a control panel with dozens of dials that affect each other. Harvard’s research indicates that one of the more significant knobs might be under the control of the FTO region.
The results also relate to a more general change in the field of obesity research. More researchers are starting to believe that fat tissue is remarkably flexible, impacted not only by nutrition and exercise but also by genetics, gut flora, and environmental cues. Certain gut bacteria have been demonstrated in other recent studies to encourage the conversion of white fat to beige fat under particular dietary circumstances.
When combined, the image becomes more intricate and captivating. Passive storage bins are not what fat cells are. They respond to chemical cues from throughout the body and genetic instructions, acting more like metabolic decision-makers.
It’s difficult to ignore how this undermines the traditional cultural narrative surrounding weight. Calorie counting and willpower have been topics of discussion for decades. However, researchers in these Boston labs are gazing at petri dishes that indicate a more subtle process is taking place. Genetic switches that were flipped long before adulthood may have an impact on an individual’s metabolism.
That does not imply that lifestyle is no longer important. Exercise and diet are still important factors. However, it does present a fascinating possibility. Future obesity treatments may differ significantly from current ones if scientists eventually figure out how to safely modify these molecular switches—possibly through medications that affect IRX3 or IRX5.
As of right now, the discovery is in that well-known early phase of scientific excitement: intriguing, promising, but unfinished. The petri dishes continue to fill. The information continues to come in. And somewhere in those quiet labs in Boston, researchers continue to observe fat cells as they make decisions about their future.










